Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The aptamer-based RNA-PROTAC
Yan Xu, Yi Yuan, Dingqiang Fu, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 86, pp. 117299-117299
Closed Access | Times Cited: 14

Showing 14 citing articles:

Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 22
PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 21
Leveraging aptamers for targeted protein degradation
Zhihao Yang, Qiuxiang Pang, Jun Zhou, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 776-785
Closed Access | Times Cited: 23
RNATACs: Multispecific small molecules targeting RNA by induced proximity
Yan Song, Jia Cui, Jiaqiang Zhu, et al.
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1101-1117
Open Access | Times Cited: 11
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 10
PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access | Times Cited: 1
Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design
Yu Chen, Fengyuan Liu, Samira Pal, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 19, pp. 9582-9608
Closed Access | Times Cited: 6
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 5
Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery
Kai Zhang, Baoyin Yuan, Xiaoshuo Dai, et al.
International Journal of Biological Macromolecules (2025), pp. 141249-141249
Closed Access
RNA BINDING PROTEINS (RBPs) ON GENETIC STABILITY AND DISEASES
Abdullahi Tunde Aborode, Ohilebo Abdulateef Abass, Shaibu Nasiru, et al.
Global Medical Genetics (2025) Vol. 12, Iss. 1, pp. 100032-100032
Open Access
Utilizing aptamers in targeted protein degradation strategies for disease therapy
Li Lin, Songbo Xie, Jun Zhou, et al.
The Journal of Pathology (2025)
Closed Access
RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy
Jinze Shen, Jianqiao Shentu, Chenming Zhong, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 1
PROTAC and Molecular Glue Degraders of the Oncogenic RNA Binding Protein Lin28
Aseel Kashkush, Judith Furth‐Lavi, Jiří Hodoň, et al.
Macromolecular Bioscience (2024)
Open Access | Times Cited: 1
Nanotechnology‐Enabled Targeted Protein Degradation for Cancer Therapeutics
Wutong Zhao, Yongbin Jiang, Xiufen Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access
Page 1

Scroll to top